Compare BETR & MLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BETR | MLAB |
|---|---|---|
| Founded | 2014 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Industrial Machinery/Components |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 538.7M | 533.0M |
| IPO Year | N/A | 1995 |
| Metric | BETR | MLAB |
|---|---|---|
| Price | $25.22 | $109.03 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $40.00 | ★ $94.00 |
| AVG Volume (30 Days) | ★ 365.3K | 143.1K |
| Earning Date | 05-07-2026 | 05-27-2026 |
| Dividend Yield | N/A | ★ 0.67% |
| EPS Growth | N/A | ★ 436.11 |
| EPS | N/A | ★ 1.21 |
| Revenue | N/A | N/A |
| Revenue This Year | $55.02 | $6.07 |
| Revenue Next Year | $65.66 | $5.41 |
| P/E Ratio | ★ N/A | $89.64 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.90 | $59.63 |
| 52 Week High | $94.06 | $111.29 |
| Indicator | BETR | MLAB |
|---|---|---|
| Relative Strength Index (RSI) | 37.92 | 56.73 |
| Support Level | $24.91 | $67.65 |
| Resistance Level | $29.98 | N/A |
| Average True Range (ATR) | 2.11 | 7.65 |
| MACD | 0.16 | 0.33 |
| Stochastic Oscillator | 19.97 | 85.90 |
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.